A validation study of an Italian version of the ID Migraine: Preliminary results

被引：10

作者：

Brighina F. ^{[1
]}

Salemi G. ^{[1
]}

Fierro B. ^{[1
]}

Gasparro A. ^{[2
]}

Balletta G. ^{[3
]}

Aloisio A. ^{[3
]}

La Pegna G.B. ^{[4
]}

Randisi G. ^{[5
]}

Saporito V. ^{[6
]}

Calagna G. ^{[7
]}

Lanaia F. ^{[8
]}

Morana R. ^{[8
]}

机构：

[1] Dipartimento di Neurologia Oftalmologia, Otorinolaringoiatria e Psichiatria, Università di Palermo, I-90129 Palermo

[2] UO di Neurologia, Ospedale Villa Sofia, Palermo

[3] UO di Neurologia, Ospedale Civico, Palermo

[4] UO di Neurologia, ASL n. 2, Caltanissetta

[5] UO di Neurologia, Ospedale S. Elia, Caltanissetta

[6] Servizio Neurologia, Distretto di Bagheria, AUSL n. 6, Bagheria PA

[7] Ospedale Civico di Partitico, ASL n. 6, Partitico PA

[8] Dipartimento di Neurologia, Università' di Catania, Catania

来源：

The Journal of Headache and Pain | 2005年 / 6卷 / 4期

关键词：

Headache centers; ID migraine; Italian ID migraine; Migraine; Migraine recognition; Primary care;

D O I：

10.1007/s10194-005-0189-7

中图分类号：

学科分类号：

摘要：

Migraine is a highly prevalent and disabling disease that is substantially undiagnosed in primary care. Recently, the ID Migraine, a self-administered questionnaire, was shown to be a valid and reliable screener for migraine in primary care in the USA. To validate an Italian version of the ID Migraine, we planned a multicentric study, evaluating at least 220 patients affected by various form of headache. The responses to the questionnaire were compared with the diagnosis of headache made by a headache specialist blind to the result of the questionnaire. Sensitivity, specificity, and positive and negative predictive values for migraine were calculated. The statistical analysis on 140 patients now examined showed a very good performance of the ID Migraine with high sensitivity: 0.94 (95% CI: 0.89-0.95), specificity: 0.70 (95% CI: 0.54-0.86) and positive predictive value: 0.89 (0.82-0.95). If confirmed, these results would establish ID Migraine as a valid screening instrument for migraine in Italian headache patients and warrant further investigation in primary care to assess the validity of this ID screener in Italian population. © Springer-Verlag Italia 2005.

引用

页码：216 / 219

页数：3

共 6 条

[1]

Terwindt G.M., Ferrari M.D., Tijhuis M., Et al., The impact of migraine on quality of life in the general population: The GEM study, Neurology, 55, pp. 624-629, (2000)

[2]

Hu X.H., Markson L.E., Lipton R.B., Stewart W.F., Berger M.L., Burden of migraine in the United States: Disability and economic costs, Arch. Intern. Med., 159, pp. 813-815, (1999)

[3]

Lipton R.B., Diamond S., Reed M., Diamond M., Stewart W.F., Migraine diagnosis and treatment: Results from the American Migraine Study II, Headache, 41, pp. 646-657, (2001)

[4]

Lipton R.B., Scher A.I., Kolodner K., Liberman J., Steiner T.J., Stewart W.F., Migraine in the United States: Epidemiology and patterns of health care use, Neurology, 58, pp. 885-894, (2002)

[5]

Lipton R.B., Dodick D., Sadovsky R., Kolodner K., Endicott J., Hettiarachchi J., Harrison W., A self-administered screener for migraine in primary care The ID Migraine™ validation study, Neurology, 61, pp. 375-382, (2003)

[6]

Cephalalgia, 24, SUPPL. 1, pp. 1-160, (2004)

← 1 →